HCW Biologics

HCWBNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.191 M

$3.41 +0.00%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$7.96M

Loss-making

Shares outstanding

6,734,104

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#460Aptevo TherapeuticsAPVO$6.35M
#461Enveric BiosciencesENVB$6.24M
#462HCW BiologicsHCWB$6.19M
#463NuCanaNCNA$6.12M
#464PulmatrixPULM$6.06M

Where these numbers come from

Share counts and financials for HCW Biologics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.